Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 26/5/2020
SIETES contiene 93011 citas

 
 
 1 a 20 de 45 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
Zhu H, Bateman BT, Gray KJ, Hernandez-Diaz S, Mogun H, Starub L, Huybrechts KF. Oral fluconazole use in the first trimester and risk of congenital malformations: population based cohort study. BMJ 2020;369:20 de mayo. [Ref.ID 103628]
2.Enlace a cita originalTiene citas relacionadas Cita con resumen
Zash R, Makhema J, Shapiro RL. Neural-tube defects with dolutegravir treatment from the time of conception. N Engl J Med 2018;381:29 de agosto. [Ref.ID 102748]
3.Tiene citas relacionadas Cita con resumen
Rasmussen SA, Barfield W, Honein MA. Protecting mothers and babies — A delicate balancing act. N Engl J Med 2018:24 de julio. [Ref.ID 102747]
5. Cita con resumen
Yanovski SZ, Yanovski JA. Long-term drug treatment for obesity: a systematic and clinical review. JAMA 2013;311:74-86. [Ref.ID 96313]
6. Cita con resumen
Anónimo. New weight-loss drugs and the US obesity epidemic. Lancet 2012;380:308. [Ref.ID 93509]
8.Enlace a cita original Cita con resumen
Anónimo. Change in the pregnancy category for topiramate. Australian Prescriber 2012;35:66. [Ref.ID 93159]
10.Tiene citas relacionadas
Tomson T, Battino D, Perucca E. Major birth defects after exposure to newer-generation antiepileptic drugs. JAMA 2011;306:826-7. [Ref.ID 91017]
11.Tiene citas relacionadas
Merry L, Martin KL, Chen T. Major birth defects after exposure to newer-generation antiepileptic drugs. JAMA 2011;306:826. [Ref.ID 91016]
12. Cita con resumen
Anónimo. FDA says chronic, high-dose fluconazole use might carry risk for birth defects . U.S. Food and Drug Administration 2011:1. [Ref.ID 90912]
13.Tiene citas relacionadas Cita con resumen
Molgaard-Nielsen D, Hviid A. Newer-generation antiepileptic drugs and the risk of major birth defects. JAMA 2011;305:1996-2002. [Ref.ID 90564]
16.
Mossey PA, Little J, Munger RG, Dixon MJ, Shaw WC. Cleft lip and palate. Lancet 2009;374:1773-85. [Ref.ID 87231]
17. Cita con resumen
Crider KS, Cleves MA, Reefhuis J, Berry RJ, Hobbs CA, Hu DJ. Antibacterial medications use during pregnancy and risk of birth defects. National Birth Defects Prevention Study. Arch Pediatr Adolesc Med 2009;163:978-85. [Ref.ID 86933]
18. Cita con resumen
Stothard KJ, Tennant PWG, Bell R, Rankin J. Maternal overweight and obesity and the risk of congenital anomalies. A systematic review and meta-analysis. JAMA 2009;301:636-50. [Ref.ID 85234]
19.Enlace a cita original Cita con resumen
Llop Rius R, Bosch Ferrer M, Rodríguez Cumplido D, Diogène E. Farmacoterapéutica. AMF 2007;3:415-23. [Ref.ID 81239]
20.Tiene citas relacionadas Cita con resumen
Wilcox AJ, Lie RT, Solvoll K, Taylor J, McConnaughey DR, Abyholm F, Vindenes H, Vollset SE, Drevon CA. Folic acid supplements and risk of facial clefts: national population based case-control study. BMJ 2007;334:464-7. [Ref.ID 79425]
Seleccionar todas
 
 1 a 20 de 45 siguiente >>